Literature DB >> 10595475

FDG positron emission tomography in head and neck cancer: pitfall or pathology?

M P Stokkel1, V Bongers, G J Hordijk, P P van Rijk.   

Abstract

PURPOSE: Fluorodeoxyglucose (FDG) positron emission tomography (PET) is a functional imaging technique used for imaging and staging malignant diseases. In many oncologic situations, however, abnormal changes seen on the PET studies are not caused by tumor, which is especially true in the head and neck region. The authors present an overview of the phenomena that may confound the interpretation of the images in head and neck cancer.
MATERIALS AND METHODS: FDG PET studies were performed in patients with primary head and neck cancer and in patients in whom recurrent disease was likely. The results were correlated with clinical findings. Eight solitary cases were selected from a total of 180 patients studied. RESULTS AND
CONCLUSIONS: Benign lesions and iatrogenic and physiologic changes may show increased FDG uptake. Therefore, clinical information on previous surgical interventions and optimal patient preparation are necessary for adequate interpretation. If these prerequisites can be met, benign lesions appear to be the only lesions that may interfere with the specificity of FDG PET.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10595475     DOI: 10.1097/00003072-199912000-00009

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  4 in total

1.  Limitations of PET and PET/CT in detecting upper gastrointestinal synchronous cancer in patients with head and neck carcinoma.

Authors:  Kenichiro Yabuki; Akira Kubota; Choichi Horiuchi; Takahide Taguchi; Goshi Nishimura; Masahiko Inamori
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-06-22       Impact factor: 2.503

2.  Non-malignant FDG uptake in infradiaphragmatic adipose tissue: a new site of physiological tracer biodistribution characterised by PET/CT.

Authors:  Rachel Bar-Shalom; Diana Gaitini; Zohar Keidar; Ora Israel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-03-09       Impact factor: 9.236

Review 3.  Limitations of PET for imaging lymphoma.

Authors:  Sally F Barrington; Michael J O'Doherty
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-05-13       Impact factor: 9.236

4.  Carcinoma of unknown primary in the head and neck: The evaluation of the effectiveness of (18)F-FDG-PET/CT, own experience.

Authors:  Ewa Majchrzak; Witold Cholewiński; Wojciech Golusiński
Journal:  Rep Pract Oncol Radiother       Date:  2015-08-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.